Pacific Biosciences of California · NASDAQ: PACB · Medical Devices
Over the past week, Pacific Biosciences of California (PACB) logged about 40 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 31% bullish but is deeply split: News runs 50% bullish while X sits at just 18%. Wall Street is more constructive, with 4 of 8 analysts rating PACB a buy.
There is little buzz around PACB this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 50% buy share sits next to a crowd that ranges from X at 18% to News at 50%. No other tracker puts the two side by side.
Across 8 analysts the consensus is a Buy: 4 buy calls against 1 sell, with an average 12-month price target of $2.40.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 19 points above the crowd average of 31%, the professionals are more constructive than retail. The split is inside the crowd: News reads 50% bullish while X sits at 18%, a 32-point spread that single-source trackers miss.
Over the 30-day window, Pacific Biosciences of California (PACB) buzz held subdued around 29.8 while the price drifted up 79.2% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 18.3M shares. Updated Oct 10, 2026. Over the last 7 trading days, PACB lost 7.2%. Buzz activity in the recent week averaged 30.4 and was relatively stable, swinging between 23.3 and 37.5. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 8 of the 14 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for PACB and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live PACB sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Buy (4 / 3 / 1) |
| Crowd bullish (7d) | 31% |
| Avg price target | $2.40 |
| Most bullish source | News, 50% |
| Most bearish source | X, 18% |
| Sentiment spread | 32 pts |
| Mentions (7d) | 40 |
| Market cap | $714.9M |
| EPS · Beta | -$0.36 · 2.2 |
| Revenue (TTM) | $159.3M · -82% margin |
| Industry | Medical Devices |
Based on aggregated sentiment from Reddit, X and News sources, Pacific Biosciences of California (PACB) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 31% bullish across 3 active sources. Those sources contribute 40 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Pacific Biosciences of California (PACB) is fairly quiet with 4 mentions over the last 7 days; the 30-day context spans 4 tracked subreddits. The 7-day tone is 25% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bearish on Pacific Biosciences of California (PACB), averaging 31% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 50% bullish and X at 18%, a 32-point spread. On the professional side, 4 of 8 analysts rate PACB a buy.
Of the 8 analysts covering Pacific Biosciences of California (PACB), 4 rate it a buy, 3 a hold and 1 a sell, for a buy consensus. The average price target is $2.40. That puts the street ahead of the crowd, which averages 31% bullish.
Pacific Biosciences of California (PACB)'s cross-source average is bearish at 31% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. Reddit reads 25% bullish, News reads 50% bullish and x coverage is the most negative at 18% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Pacific Biosciences of California (PACB) at 31% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is x at 18% bullish. 3-day activity momentum is falling on X, while reddit activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 28 mentions (70% of total volume). News contributes 8 mentions and Reddit contributes 4 mentions. The cross-source average is bearish at 31% bullish, while reddit is the only source with rising 3-day activity. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. PACB's sell signal at 93/100 conviction reflects a bearish cross-source average at 31% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The PACB sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key